The past year hasn't been kind to the stocks featured in this article.
Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Inter Parfums (NASDAQ:IPAR) and the best and worst performers in the personal care industry.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at personal care stocks, starting with Medifast (NYSE:MED).
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Estée Lauder (NYSE:EL) and its peers.
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Shareholders of Coty would probably like to forget the past six months even happened. The stock has dropped 42.5% and now trades at a new 52-week low of $5.40. This was partly driven by its softer quarterly results and may have investors wondering how to approach the situation.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at personal care stocks, starting with USANA (NYSE:USNA).
Let’s dig into the relative performance of The Honest Company (NASDAQ:HNST) and its peers as we unravel the now-completed Q4 personal care earnings season.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the personal care industry, including e.l.f. Beauty (NYSE:ELF) and its peers.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the personal care industry, including BeautyHealth (NASDAQ:SKIN) and its peers.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Coty (NYSE:COTY) and its peers.
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums).
That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.
Stifel analyst Mark S. Astrachan lowered Coty's price target from $8.5 to $8, maintaining a Hold rating. Despite adjusted EBITDA growth, Coty's second-quarter FY25 results revealed a 1% YoY decline in net revenue and a challenging outlook for the second half of FY25.
Beauty products company Coty (NYSE:COTY) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 3.3% year on year to $1.67 billion. Its non-GAAP profit of $0.11 per share was 47.7% below analysts’ consensus estimates.
